🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.50
-0.90 (-3.17%)
Nov 20, 2026, 1:30 PM CST

TPEX:4111 Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
186.21164.28110.6368.67154.0180.75
Depreciation & Amortization
68.2674.2566.361.9672.8879.08
Loss (Gain) From Sale of Assets
-0.470.822.380.134.96-0.12
Asset Writedown & Restructuring Costs
------6.8
Provision & Write-off of Bad Debts
-0.010.010.01--00
Other Operating Activities
-3.3858.1626.08-17.01-17.1632.71
Change in Accounts Receivable
-7.05-23.99-28.25-26.69.17-36.81
Change in Inventory
-8.42-6.53-7.689.86-8.83-4.86
Change in Accounts Payable
21.02117.5822.41-16.4917.54.76
Change in Unearned Revenue
3.4-0.13-1.03-3.6-3.02-4.21
Change in Other Net Operating Assets
-4.74-109.8422.34-2.410.6321.78
Operating Cash Flow
254.82274.61213.274.52214.86139.33
Operating Cash Flow Growth
4.07%28.80%186.10%-65.32%54.21%-2.93%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-134.31-93.86-84.19-101.5-105.33-264.86
Sale of Property, Plant & Equipment
0.510.590.310.410.070.12
Divestitures
----168.97-
Sale (Purchase) of Intangibles
-0.1-0.68-1.03-0.5-0.52-0.65
Sale (Purchase) of Real Estate
--1.86----
Investment in Securities
-0.5----1.37
Other Investing Activities
0.12-1.36-1.424.970.06-25
Investing Cash Flow
-134.27-97.17-86.31-76.6163.24-289.02

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----130
Total Debt Issued
-----130
Short-Term Debt Repaid
---110--10-
Long-Term Debt Repaid
--12.76-4.77-5.65-7.03-6.46
Lease Payments
-9.79-12.76-4.77-5.65-7.03-6.46
Total Debt Repaid
-9.79-12.76-114.77-5.65-17.03-6.46
Net Debt Issued (Repaid)
-9.79-12.76-114.77-5.65-17.03123.54
Common Dividends Paid
-134.77-56.98-56.98-68.38-56.98-56.98
Other Financing Activities
00.0100.92-0.870.12
Financing Cash Flow
-144.55-69.73-171.75-73.11-74.8866.68

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
----0.77-0.52
Net Cash Flow
-24107.72-44.86-75.21203.98-83.53

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
120.51180.75129.01-26.98109.53-125.53
Free Cash Flow Growth
-18.72%40.11%----
Free Cash Flow Margin
8.41%13.13%11.07%-2.54%9.58%-12.28%
Free Cash Flow Per Share
1.992.992.15-0.451.82-2.09
Levered Free Cash Flow
46.74161.4340.28-50.71105.66-140.99
Unlevered Free Cash Flow
47161.7641.37-49.8106.61-140.31
Free Cash Flow After Leases
110.72167.99124.24-32.63102.5-131.99

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.420.521.851.441.51.03
Cash Income Tax Paid
56.13-15.551.4134.7425.3918.44
Change in Working Capital
4.21-22.927.79-39.2425.45-19.35